Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Lantern Pharma Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
BC
BIOS Capital Management, LP
13D · 4.5%
|
249.4K | 1.95% | −615.0K (−71.1%) | 2024 | 2.5% | |
|
Shares held by quarter
Peak holding1.2M (Q4'24)
Change over 8 quarters+249.4K
Share of the company1.950%
Disclosed stake13D · 4.5%
|
||||||
|
EA
Empery Asset Management, LP
|
842.7K | 6.59% | NEW | Q2 '26 | 4.1% | |
|
Shares held by quarter
Peak holding842.7K (Q2'26)
Change over 8 quarters+842.7K
Share of the company6.590%
|
||||||
28 more super investors behind a free account
See every manager holding Lantern Pharma Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$1.41M | 338.4K | 2.65% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$338K | 81.1K | 0.63% | 0.00% | June 30, 2026 |
13 more funds behind a free account
See every fund holding Lantern Pharma Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LW
Leslie W. Kreis
5%+ holder
13D · 4.5%
|
571.3K | 4.47% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
CA
Cavu Advisors, LLC
5%+ holder
13D · 4.5%
|
571.3K | 4.47% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of Lantern Pharma Inc.
Sign up freeLoading...